An innovation born out of frustration can give a huge boost to laboratory research into new treatments and medicines. Researchers Martijn Verdoes, theme Nanomedicine, and Bas van der Schoot, theme Cancer development and immune defense, together with Ferenc Scheeren, Leiden University Medical Centre, developed a technique to engineer and produce antibodies quickly, easily and cheaply. "This new technique will open up the field." The researchers published their results in the open access journal Science Advances.
Antibodies play a crucial and growing role in cancer treatment, immunotherapy and diagnostics. Antibodies recognise a cancer cell or another cell very specifically. Fundamental researchers also use antibodies in their research and in the development of new therapies. At present, however, producing and engineering antibodies is a lengthy, specialized and expensive process, which is consequently carried out mainly by biotechnology companies.
Easy, cheap and fast
This is a source of great frustration for researchers such as Scheeren and Verdoes. "We have all kinds of ideas for new research, but we were hampered because we couldn't engineer antibodies ourselves", Scheeren explains. The recent CRISPR-Cas technology offered a solution. "Using this new technique, we can easily, quickly and cheaply introduce genetic modifications in cells continuously producing large amounts of antibodies, so called hybridoma cells. This enabled us to produce large quantities of antibody variants to which we have made a variety of functional modifications, in a short period of time", says Bas van der Schoot, first author of the article.
The researchers believe that their discovery breaks open the field for the use of antibodies in the research phase. “Tinkering with an antibody can provide a great deal of information about its mode of actions”, says Verdoes. “We can also introduce completely new elements and learn step by step how to make the antibody increasingly effective for clinical use. Using our technique, this can now be done at low cost and in a short period of time."
Several fellow-researchers have already responded enthusiastically, according to Scheeren. "Almost every laboratory able to culture cells – and there are many of them – can use this effective technique." The researchers therefore make their reagents publicly available on the addgene.com website.
This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 679921).
Related news items
Online intervention for women exposed to intimate partner violence21 November 2019
Within the SAFE project from the department of Primary and Community Care an eHealth intervention has been developed for women exposed to intimate partner violence (IPV).read more
A personal touch of Sander Leeuwenburgh21 November 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Sander Leeuwenburgh.read more
Technology for Oncology II grant application funded21 November 2019
The grant application called "aiREAD – Accurate and Intelligent Reading for EArlier breast cancer Detection” by project leader Ioannis Sechopoulos, has been selected for funding under the NWO TTW – KWF Kankerbestrijding – Top Sector LSH Partnership “Technology for Oncology II”.read more
KNCV Golden Master Award call for nominations20 November 2019
The Royal Netherlands Chemistry Society awards this prize each year to the best Master’s research project. The Master’s thesis must relate to research in the field of chemistry, life sciences, process technology or (bio-)molecular sciences. Deadline: 31-12-2019.read more
Podosome nanoscale architecture redefined20 November 2019
Koen van den Dries and Alessandra Cambi, theme Nanomedicine, revealed how the nanoscale architecture of podosomes enables dendritic cells to protrude and sense their extracellular environment. They have published their results in Nature Communications.read more
270 times Homo Universalis in Nijmegen20 November 2019
What does a scientist of the future look like? International young scientists addressed this important topic during the ENABLE conference, organized by young researchers for young researchers. They showed how the new generation of researchers wants to open up science to the public.read more